Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
|
Mid-range Performer
1003.4000
1.10
(
0.11
%)
NSE
Jul 10, 2025
10:49 AM
Volume:
10,916
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
29 Apr 2024
1003.40
0.11%
Glenmark Life Science
Buy:
Alivus Life Sciences Ltd.
by
ICICI Direct
Target: 1040
ICICI Direct
Alivus Life Sciences Ltd. is trading below all available SMAs
More from Alivus Life Sciences Ltd.
Recommended
Market trades lower, Oil India signs a 15-year supply agreement with GAIL
Trendlyne Marketwatch |
10 Jul 2025, 10:50AM
All in the family: Bajaj, Murugappa, Mahindra & Tata Group stocks outpace the benchmark
The Baseline |
09 Jul 2025, 04:24PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021